BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26560738)

  • 1. Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors.
    Gamo AM; González-Vera JA; Rueda-Zubiaurre A; Alonso D; Vázquez-Villa H; Martín-Couce L; Palomares Ó; López JA; Martín-Fontecha M; Benhamú B; López-Rodríguez ML; Ortega-Gutiérrez S
    Chemistry; 2016 Jan; 22(4):1313-21. PubMed ID: 26560738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptors: in silico drug discovery in 3D.
    Becker OM; Marantz Y; Shacham S; Inbal B; Heifetz A; Kalid O; Bar-Haim S; Warshaviak D; Fichman M; Noiman S
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11304-9. PubMed ID: 15277683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting the chemical space around the (iso)indoline scaffold, a comprehensive approach towards multitarget directed ligands.
    Éliás O; Kovács Z; Wágner G; Némethy Z; Tarcsay Á; Greiner I
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4211-5. PubMed ID: 27496213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational studies to predict or explain G protein coupled receptor polypharmacology.
    Jacobson KA; Costanzi S; Paoletta S
    Trends Pharmacol Sci; 2014 Dec; 35(12):658-63. PubMed ID: 25458540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity in agonist and antagonist binding to Serotonin
    Rao BD; Sarkar P; Chattopadhyay A
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183265. PubMed ID: 32156647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quo vadis G protein-coupled receptor ligands? A tool for analysis of the emergence of new groups of compounds over time.
    Leśniak D; Jastrzębski S; Podlewska S; Czarnecki WM; Bojarski AJ
    Bioorg Med Chem Lett; 2017 Feb; 27(3):626-631. PubMed ID: 27993519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential dynamics of the serotonin1A receptor in membrane bilayers of varying cholesterol content revealed by all atom molecular dynamics simulation.
    Patra SM; Chakraborty S; Shahane G; Prasanna X; Sengupta D; Maiti PK; Chattopadhyay A
    Mol Membr Biol; 2015; 32(4):127-37. PubMed ID: 26508556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.
    Ofori E; Zhu XY; Etukala JR; Peprah K; Jordan KR; Adkins AA; Bricker BA; Kang HJ; Huang XP; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2016 Aug; 24(16):3464-71. PubMed ID: 27312422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction?
    Paila YD; Chattopadhyay A
    Glycoconj J; 2009 Aug; 26(6):711-20. PubMed ID: 19052861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol interaction motifs in G protein-coupled receptors: Slippery hot spots?
    Sarkar P; Chattopadhyay A
    Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1481. PubMed ID: 32032482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of machine learning in GPCR bioactive ligand discovery.
    Jabeen A; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():66-76. PubMed ID: 31005679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Co-immunoprecipitation and Immunoblot Approach to Determine Oligomerisation of G-Protein-Coupled Receptors.
    Guest PC
    Adv Exp Med Biol; 2017; 974():237-243. PubMed ID: 28353241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors.
    Allen JA; Roth BL
    Annu Rev Pharmacol Toxicol; 2011; 51():117-44. PubMed ID: 20868273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor.
    Yuan S; Peng Q; Palczewski K; Vogel H; Filipek S
    Angew Chem Int Ed Engl; 2016 Jul; 55(30):8661-5. PubMed ID: 27244650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring GPCR-Lipid Interactions by Molecular Dynamics Simulations: Excitements, Challenges, and the Way Forward.
    Sengupta D; Prasanna X; Mohole M; Chattopadhyay A
    J Phys Chem B; 2018 Jun; 122(22):5727-5737. PubMed ID: 29685028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCRs steer G
    Huang S; Xu P; Shen DD; Simon IA; Mao C; Tan Y; Zhang H; Harpsøe K; Li H; Zhang Y; You C; Yu X; Jiang Y; Zhang Y; Gloriam DE; Xu HE
    Mol Cell; 2022 Jul; 82(14):2681-2695.e6. PubMed ID: 35714614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands.
    Freudenberg JM; Dunham I; Sanseau P; Rajpal DK
    BMC Bioinformatics; 2018 Oct; 19(1):345. PubMed ID: 30285606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Choose the Suitable Template for Homology Modelling of GPCRs: 5-HT7 Receptor as a Test Case.
    Shahaf N; Pappalardo M; Basile L; Guccione S; Rayan A
    Mol Inform; 2016 Sep; 35(8-9):414-23. PubMed ID: 27546045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.